Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial

NCT07030621 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

436

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Semaglutide 0.5 mg
DRUG: Normal Saline

Sponsor

RenJi Hospital